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ﺍﻟﻤﻠﺨﺺ
ﺃﻫﺪﺍﻑﺍﻟﺒﺤﺚ:ﻟﻢﻳﺪﺭﺱﺗﺄﺛﻴﺮﻓﺮﻁﺍﻟﺴﺨﻮﻧﺔﻋﻠﻰﻋﻤﻞﺍﻟﻐﺪﺩﺍﻟﻌﺮﻗﻴﺔﺃﺛﻨﺎﺀﺍﻟﻀﺮﺑﺔ
ﺍﻟﺤﺮﺍﺭﻳﺔﺑﺸﻜﻞﺟﻴﺪ.ﻭﺗﻬﺪﻑﻫﺬﻩﺍﻟﺪﺭﺍﺳﺔﻟﺘﻘﻴﻴﻢﺗﻐﻴﻴﺮﺗﺮﻛﻴﺰﺍﻟﻜﻠﻮﺭﻳﺪﻓﻲﺍﻟﻌﺮﻕﻗﺒﻞ
ﻭﺑﻌﺪﺍﻟﻨﻘﺎﻫﺔﻣﻦﺍﻟﻀﺮﺑﺔﺍﻟﺤﺮﺍﺭﻳﺔ.
ﻃﺮﻕﺍﻟﺒﺤﺚ:ﺗﻢﻗﻴﺎﺱﺍﻟﻜﻠﻮﺭﻳﺪﻓﻲﺍﻟﻌﺮﻕﺇﺛﺮﺍﻟﺘﺤﻔﻴﺰﺑﺎﺳﺘﻌﻤﺎﻝﺍﻟﺒﻴﻠﻮﻛﺎﺭﺑﻴﻦﻋﻨﺪ
10ﻣﺮﺿﻰﻣﺼﺎﺑﻴﻦﺑﺎﻟﻀﺮﺑﺔﺍﻟﺤﺮﺍﺭﻳﺔﻋﻨﺪﺩﺧﻮﻝﺍﻟﻤﺴﺘﺸﻔﻰﻭﺑﻌﺪ12ﺳﺎﻋﺔ.ﻛﻤﺎ
ﺗﻤﺖﺍﻟﻤﻘﺎﺭﻧﺔﻣﻊ7ﻣﺮﺿﻰﻣﺼﺎﺑﻴﻦﺑﺎﻹﻧﻬﺎﻙﺍﻟﺤﺮﺍﺭﻱﻭ10ﻣﺮﺿﻰﻣﺼﺎﺑﻴﻦ
ﺑﺎﻹﺟﻬﺎﺩﺍﻟﺤﺮﺍﺭﻱ.
ﺍﻟﻨﺘﺎﺋﺞ:ﺑﻠﻎﻣﺘﻮﺳﻂﺃﻋﻤﺎﺭﻣﺮﺿﻰﺍﻟﻀﺮﺑﺔﺍﻟﺤﺮﺍﺭﻳﺔ51.1±8.9ﻋﺎﻣﺎ.ﻭﻛﺎﻥ
ﻣﺘﻮﺳﻂﺣﺮﺍﺭﺓﺍﻟﻤﺴﺘﻘﻴﻢ42.9±0.6ﺩﺭﺟﺔﻣﺌﻮﻳﺔ.ﻭﻛﺎﻥﻣﺘﻮﺳﻂﻭﻗﺖﺍﻟﺘﺒﺮﻳﺪ
96±12ﺩﻗﻴﻘﺔ،ﻭﺑﻠﻎﻣﻘﻴﺎﺱﺃﺑﺎﺗﺸﻲ2؛23.5±6.9،ﻭﻛﺎﻥﺗﺮﻛﻴﺰﻻﻛﺘﺎﺕ
ﺍﻟﻤﺼﻞ5.2±2.1ﻣﻠﻤﻮﻝ/ﻝ.ﻭﻛﺎﻥﻣﺘﻮﺳﻂﺗﺮﻛﻴﺰﺍﻟﻜﻠﻮﺭﻳﺪﻓﻲﺍﻟﻌﺮﻕﻣﻨﺨﻔﻀﺎ
ﺑﺪﺭﺟﺔﻣﻠﺤﻮﻇﺔﻋﻨﺪﻣﺮﺽﺍﻟﻀﺮﺑﺔﺍﻟﺤﺮﺍﺭﻳﺔ)5.3±0.6ﻣﻠﻤﻮﻝ/ﻝ(ﻣﻘﺎﺭﻧﺔﻣﻊ
ﻣﺮﺿﻰﺍﻹﻧﻬﺎﻙﺍﻟﺤﺮﺍﺭﻱ)20±1.5ﻣﻠﻤﻮﻝ/ﻝ،Pﺃﺻﻐﺮﻣﻦ0.0001(
ﻭﻣﺮﺿﻰﺍﻹﺟﻬﺎﺩﺍﻟﺤﺮﺍﺭﻱ)27±3.2ﻣﻠﻤﻮﻝ/ﻝ،Pﺃﺻﻐﺮﻣﻦ0.0001(.
ﻭﻛﺎﻥﻣﺘﻮﺳﻂﺗﺮﻛﻴﺰﺍﻟﻜﻠﻮﺭﻳﺪﺑﻌﺪ12ﺳﺎﻋﺔﻋﻨﺪﻣﺮﺿﻰﺍﻟﻀﺮﺑﺔﺍﻟﺤﺮﺍﺭﻳﺔ
ﺍﻟﺜﻤﺎﻧﻴﺔﺍﻟﺬﻳﻦﺑﻘﻮﺍﻋﻠﻰﻗﻴﺪﺍﻟﺤﻴﺎﺓﻗﺪﺍﺯﺩﺍﺩﺇﻟﻰ17.9±6.6ﻣﻠﻤﻮﻝ/ﻝ،ﺑﻴﻨﻤﺎﺑﻘﻲ
ﺗﺮﻛﻴﺰﺍﻟﻜﻠﻮﺭﻳﺪﺩﻭﻥﺗﻐﻴﻴﺮﻋﻨﺪﻣﺮﺿﻰﺍﻟﻀﺮﺑﺔﺍﻟﺤﺮﺍﺭﻳﺔﺍﻟﺬﻳﻦﺗﻮﻓﻮﺍ)Pﺃﺻﻐﺮ
ﻣﻦ0.0001(.
ﺍﻻﺳﺘﻨﺘﺎﺟﺎﺕ:ﺍﻧﺨﻔﺾﺗﺮﻛﻴﺰﺍﻟﻜﻠﻮﺭﻳﺪﻓﻲﺍﻟﻌﺮﻕﻋﻨﺪﻣﺮﺿﻰﺍﻟﻀﺮﺑﺔﺍﻟﺤﺮﺍﺭﻳﺔ
ﺑﺸﻜﻞﻭﺍﺿﺢﻣﻘﺎﺭﻧﺔﺑﻤﺮﺿﻰﺍﻹﻧﻬﺎﻙﺍﻟﺤﺮﺍﺭﻱﻭﺍﻹﺟﻬﺎﺩﺍﻟﺤﺮﺍﺭﻱ،ﻭﺍﺭﺗﻔﻊ
ﺗﺮﻛﻴﺰﺍﻟﻜﻠﻮﺭﻳﺪﻓﻲﺍﻟﻌﺮﻕﺑﻌﺪ12ﺳﺎﻋﺔﻣﻦﺍﻟﻌﻼﺝﻋﻨﺪﻣﺮﺿﻰﺍﻟﻀﺮﺑﺔ
ﺍﻟﺤﺮﺍﺭﻳﺔ.
ﺍﻟﻜﻠﻤﺎﺕﺍﻟﻤﻔﺘﺎﺣﻴﺔ:ﺍﻟﻀﺮﺑﺔﺍﻟﺤﺮﺍﺭﻳﺔ;ﺍﻹﻧﻬﺎﻙﺍﻟﺤﺮﺍﺭﻱ;ﻛﻠﻮﺭﻳﺪﺍﻟﻌﺮﻕ
Abstract
Objective: The effect of hyperpyrexia on sweat gland func-
tion in heat stroke (HS) has been poorly studied. The aim of
this study was to assess changes in sweat chloride concen-
tration before and after recovery from heat stroke.
Methods: Sweat chloride concentration in response to pilo-
carpine stimulation was measured in 10 HS patients on
admission and after 12 h and was compared with that of
7 heat exhaustion (HE) and 10 heat stress patients.
Results: The mean age of HS patients was 51.1
± 8.9 years. Their mean rectal temperature was 42.9
± 0.6 C, cooling time was 96 ± 12 min, APACHE II score
was 23.5 ± 6.9, and serum lactate concentration was 5.2
± 2.1 mmol/L. The mean sweat chloride concentration
was significantly lower among HS patients (5.3 ±
0.6 mmol/L) compared with HE (20.0 ± 1.5 mmol/L,
p< 0.0001) and heat stress patients (27 ± 3.2 mmol/L,
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p< 0.0001). The mean sweat chloride concentration at 12 h
among 8 HS patients who survived increased to 17.9
± 6.6 mmol/L, whereas in 2 HS patients who died, the
sweat chloride concentration remained unchanged
(p< 0.0001).
Conclusion: Sweat chloride concentration in HS was mark-
edly reduced compared to HE and heat stress. However, in
HS patients who survived, sweat chloride concentration
recovered 12 h after treatment.
Keywords: Heat stroke; Heat exhaustion; Sweat chloride
 2014 Taibah University. Production and hosting by Elsevier
Ltd. All rights reserved.
Table 1: Characteristics of 10 heat stroke patients.
Variable Value*
Gender, n
Male 4
Female 6
Age (years) 51.1 ± 8.9
Rectal temp (C) 42.9 ± 0.6
Mean arterial pressure (mm Hg) 77.5 ± 20.6
Respiration rate (min1) 34 ± 11
Cooling time (min) 96 ± 12
Glasgow Coma Scale 6.5 ± 6.9
APACHE-II 23.5 ± 6.9
Na+(mmol/L) 135.9 ± 5.7
K+(mmol/L) 3.57 ± 0.7
Cl (mmol/L) 104.4 ± 4.9
CO2 (mmol/L) 19.1 ± 6.3
Urea (mmol/L) 7.25 ± 2.7
Creatinine (lmol/L) 142 ± 55
Lactate (mmol/L) 5.2 ± 2.1
* Except as indicated, values are mean ± SD.
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Classic heat stroke (HS) is a medical emergency that leads to
significant morbidity and mortality if left untreated.1–4 In hot
climatic conditions, marked elevation of body temperature in
HS patients results in cutaneous vasodilatation and a shift of
splanchnic blood flow to the skin to increase heat dissipation
and prevent a further increase in body temperature.1,5 There-
fore classic HS victims have hot, dry, and flushed skin as op-
posed to exertional HS patients who exhibit excessive
sweating.1,6–8 This highlights the vital role of an efficient
sweating mechanism in thermoregulation.6–9 Previous studies
in HS have suggested that sweat glands become dysfunctional
or may even be destroyed in response to intense heat, however,
a literature search failed to yield subsequent corroborative
data.9,10 Therefore, we measured chloride concentration in
pilocarpine-induced sweat of patients with HS before and
12 h after initiation of therapy, and compared baseline chlo-
ride levels with those of heat exhaustion (HE) and heat stress
patients.
Materials and Methods
This study was conducted at the Heat Stroke Centre of
Al-Noor Hospital, Makkah, Saudi Arabia during the 1998
pilgrimage, when peak environmental temperatures reached
almost 45 C. The Ethics Committee of College of Medicine
Research Centre (CMRC), King Saud University, Riyadh,
approved the study, and informed consent was obtained from
patients or their relatives.
We studied 10 consecutive Saudi patients, 6 of them were
females, mean age of 51.1 ± 8.9 years, who fulfilled the diag-
nosis of HS: rectal temperatureP 40 C, deterioration of level
of consciousness, and hot dry skin after exposure to heat.1
Tests to exclude sepsis and meningitis were routinely per-
formed. Clinical assessments included full neurological exami-
nation, Glasgow Coma Scale (GCS), Acute Physiological and
Chronic Health Evaluation II (APACHE II) score, and rectal
temperature. Serum sodium, potassium, urea, creatinine, and
lactate levels were measured on admission. Cooling was started
immediately by evaporation methods as previously described.
11 Cooling time, defined as the time required to reduce the rec-
tal temperature to 38.9 C, was also recorded. Peripheral sweat
production was induced by pilocarpine (0.5% pilocarpinenitrate agar gel) iontophoresis, injected intradermally in the
ventral side of the forearm 3 to 4 cm distal to the antecubital
fossa.12 Two cycles of pilocarpine iontophoresis were per-
formed using a Webster Sweat Inducer (Model 3700, Wescor,
Logan, UT, USA). The Orion Skin Chloride-selective Elec-
trode (Orion Model 417 Skin Chloride Measuring System, Or-
ion Research Inc., Cambridge, MA, USA) was used to
measure sweat chloride level according to the manufacturer’s
recommended procedure. The electrode was calibrated with a
standard chloride solution (20–100 mmol/L) at room tempera-
ture. Sweat chloride was measured for each HS patient on
admission and at 12 h post admission. Sweat chloride was also
measured on admission in 7 patients (2 of them females) with
HE and 8 (out of them one female) with heat stress. HE was
defined as a rectal temperature between 37 C and 40 C with
generalized fatigability, thirst and weakness while heat stress
patients had no fever and were admitted to the emergency
room with other medical illnesses after exertion in a hot, sunny
environment.
Statistical analyses were performed using SPPS PC+ ver-
sion 16.0. Mean and standard deviations (SD) were calculated
for each variable. Data were compared between groups using
the paired or unpaired t-test, as appropriate. Significance
was accepted at p< 0.05.
Results
The mean rectal temperature in HS patients was 42.9 ± 0.6 C
(range: 41.9–44.2 C). Their GCS score was 6.5 ± 6.9 and
APACHE-II was 23.5 ± 6.9. The cooling time was 96
± 12 min (Table 1).
Mean sweat chloride concentration on admission in HS pa-
tients (5.3 ± 0.6 mmol/L) was significantly lower than in HE
patients (20.0 ± 1.5 mmol/L (t= 28.3; p< 0.0001) and in
heat stress patients (27.0 ± 3.2 mmol/L (t= 21.1; p<
0.0001) (Fig. 1). The Door to sweat test time for all patients
was 2.5 ± 1.5 min.
Eight HS patients survived and their vital signs returned to
normal within 12 h of admission, 2 patients developed multi-
organ dysfunction syndrome and died within 24 h of
admission. The mean level of sweat chloride 12 h post admis-
sion was higher in survivors (17.9 ± 6.6 mmol/L) than in non-
survivors (5.1 ± 0.5; t= 5.9: p< 0.0001), whose chloride
concentrations were unchanged compared with their values
at admission (Fig. 2).
Discussion
In this study, the chloride concentrations in pilocarpine-in-
duced sweat of HS patients were significantly lower than those
of HE or heat stressed patients. Following 12 h of routine
cooling and fluid replacement, sweat chloride concentrations
have approached or reached normal levels in HS patients,
who survived, unlike non-survivors whose chloride concentra-
tions did not change from baseline. Previous studies in HS
patients have shown an initial increase in sweating for up to
6 h followed by a substantial decrease.3,6,13,14 This inhibition
of sweating occurs together with impaired level of conscious-
ness at high body temperature.6,10,15,16 All of our HS patients
had temperatures above 42 C, and had reached the stage of
anhydrosis.
The association of anhydrosis with classic HS is part of a
general failure of heat dissipating mechanism. It is known that
HS causes damage to most body cells. In humans, a core tem-
perature of approximately 42 C for 45 min to 8 h has been
established as thermal maximum after which cellular
destruction will occur.15–17 Reversible sweat gland ‘‘fatigue”
is thought to precede their permanent destruction.18 An early
electron microscopy study demonstrated degeneration of the
superficial and basal cells of the sweat glands of patients
who died of HS.10 Consistent with this report, the sweat chlo-
ride concentrations in the 2 patients who died in our study,
failed to increase after 12 h of therapy, while the 8 surviving
patients experienced recovery of sweat chloride levels. These
findings, therefore, suggest that irreversible destruction of
sweat glands must have occurred in the patients who died,
and that failure of chloride concentrations to recover is associ-
ated with fatal outcome.
Several mechanisms could explain the observed impairment
in sweating function. First, the body thermoregulatory
response by the hypothalamus is disrupted. In normal condi-
tions, elevation of body temperature triggers the hypothalamus
to send efferent impulses to the skin, eliciting vasodilation and
sweating to dissipate heat in a coordinated autonomic
response.17 Thus, temporary dysfunction of the hypothalamus
due to high body temperature may produce a deleterious effect
on sweat gland function.19 Second, hormonal regulatory mech-
anisms may be involved. Alterations in the levels of cortisone,
growth hormone and mineralocorticoids, have been shown to
occur in HS victims.20 These hormones are known to affect the
sweating mechanism both directly by affecting the sweat gland
function and indirectly by modulating the thermoregulatory
centre in the hypothalamus.21 Third, hyperthermia may dis-
turb the autonomic nervous system, thereby affecting sweat
gland function.22–24 Fourth, fluid replacement in patients
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Figure 1: Sweat chloride concentration in heat stroke, heat exhaustion and heat stress patients.
Figure 2: Sweat chloride concentration at 0 and 12 h of 10 heat
stroke patients.
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who survived, may have been contributed to the restoration of
sweating in these patients.20
The results of the present study suggests that sweat chloride
concentration may be a marker for sweat gland fatigue and
that failure of chloride to recover can be used as a surrogate
for sweat gland destruction and may; along with other mark-
ers; indicate a worse outcome. Although, measuring sweat
chloride concentration in response to pilocarpine stimulation
cannot be used as a single predictor of whole body sweating,
it is more practical than either measuring the amount of sweat
or performing biopsy and subsequent histological evaluation
of the sweat glands. Although these preliminary data provide
a valuable insight into sweat gland function in survivors and
non-survivors of HS victims, our study is limited by the small
number of patients and the lack of indices for environmental
heat stress such as Wet Bulb Globe Temperature score. This
has precluded the evaluation of physiological correlates that
may be associated with sweat gland destruction.
Another limitation is the use of the old model (417) of skin
chloride measuring system, as it was the only one available at
the time, and perhaps future studies in HS with new advanced
measuring systems can evaluate alteration in sweat gland func-
tion more precisely.
In conclusion, this study demonstrates that the sweating
function in HS victims is disturbed significantly, but is a tem-
porary phenomenon in survivors. Accordingly, these prelimin-
ary findings need to be confirmed in a large cohort of HS
patients, in whom the neurohormonal mechanisms associated
with sweat gland morphology and function are elucidated.
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